Compagnie Lombard Odier SCmA’s OptimizeRx OPRX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.58K	Hold	410	–	–	﹤0.01%	407
2025 Q4	$5.03K	Hold	410	–	–	﹤0.01%	395
2025 Q3	$8.4K	Hold	410	–	–	﹤0.01%	411
2025 Q2	$5.54K	Hold	410	–	–	﹤0.01%	399
2025 Q1	$3.55K	Hold	410	–	–	﹤0.01%	445
2024 Q4	$1.99K	Hold	410	–	–	﹤0.01%	429
2024 Q3	$3.17K	Hold	410	–	–	﹤0.01%	431
2024 Q2	$4.1K	Hold	410	–	–	﹤0.01%	410
2024 Q1	$4.98K	Hold	410	–	–	﹤0.01%	440
2023 Q4	$5.87K	Hold	410	–	–	﹤0.01%	507
2023 Q3	$3.19K	Hold	410	–	–	﹤0.01%	552
2023 Q2	$5.86K	Hold	410	–	–	﹤0.01%	525
2023 Q1	$6K	Hold	410	–	–	﹤0.01%	569
2022 Q4	$7K	Hold	410	–	–	﹤0.01%	623
2022 Q3	$6K	Hold	410	–	–	﹤0.01%	587
2022 Q2	$11K	Hold	410	–	–	﹤0.01%	541
2022 Q1	$15K	Buy	+410	New	+$18.1K	﹤0.01%	536

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Compagnie Lombard Odier SCmA's OPRX Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA held its OptimizeRx (OPRX) position steady in Q1 2026 at 410 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Compagnie Lombard Odier SCmA first reported a position in OPRX in Q1 2022 and has held it in 17 quarters since. The position peaked at $15K in Q1 2022. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Compagnie Lombard Odier SCmA held 410 shares of OptimizeRx worth $2.58K as of Q1 2026.
Compagnie Lombard Odier SCmA left its OptimizeRx share count unchanged in Q1 2026.
OptimizeRx made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #407 holding.
Compagnie Lombard Odier SCmA first reported a position in OptimizeRx in Q1 2022 and has held it in 17 quarters since.
Compagnie Lombard Odier SCmA's OptimizeRx position peaked at $15K in Q1 2022.
127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.